Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of 0.01%, 0.03%, and 0.05% Atropine Eye Drops in Reducing Myopia Progression
NCT07626892Phase 3Completed
- Sponsor
- Khyber Medical College
- Start
- Jun 2024
- Primary completion
- May 2026
- Countries
- 1
01
Overview
A Phase 3 trial of NVK002 in myopia, sponsored by Khyber Medical College. Started Jun 2024; status: completed.
02
Drugs
NVK002
03
Conditions
myopia
Beyond the preview
Go deeper on NCT07626892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07626892.